止血剤・組織密閉剤の世界市場:製品別(局所止血剤、接着剤・組織シーラント)、地域別、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product (Topical Hemostat, Adhesives & Tissue Sealant), By Region, And Segment Forecasts, 2019 - 2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hemostasis and Tissue Sealing Agents Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.1.1. Increasing incidence rate of chronic conditions
3.7.1.2. Applicability of products across multiple conditions
3.7.1.3. Growing geriatric population
3.7.2. Market Restraint Analysis
3.7.2.1. Stringent regulations and approvals
3.7.3. Industry Challenges
3.7.3.1. Associated complications
3.8. Hemostasis and Tissue Sealing Agents: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (High)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (High)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
3.8.5. Case Studies
Chapter 4. Hemostasis and Tissue Sealing Agents Market: Segment Analysis, By Product, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Component market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Hemostasis and Tissue Sealing Agents Market, By Product, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Topical hemostats
4.5.1.1. Active
4.5.1.2. Mechanical
4.5.1.3. Flowable
4.5.2. Adhesive & tissue sealant
4.5.2.1. Synthetic
4.5.2.2. Natural
4.5.2.3. Adhesion barrier
Chapter 5. Hemostasis and Tissue Sealing Agents Market: Regional Market Analysis, By Region, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Regional market share analysis, 2018 & 2026
5.3. Regional Market Dashboard
5.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
5.5. Regional Market Share and Leading Players, 2018
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
5.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
5.7. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2026:
5.8. North America
5.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.8.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.8.3. U.S.
5.8.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.8.4. Canada
5.8.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9. Europe
5.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.9.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.3. Germany
5.9.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.4. U.K.
5.9.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.5. France
5.9.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.6. Italy
5.9.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.9.7. Spain
5.9.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10. Asia Pacific
5.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.10.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.3. China
5.10.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.4. Japan
5.10.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.5. India
5.10.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.6. Thailand
5.10.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.10.7. South Korea
5.10.7.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11. Latin America
5.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.11.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.3. Brazil
5.11.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.4. Mexico
5.11.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.5. Argentina
5.11.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.11.6. Colombia
5.11.6.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12. Middle East and Africa
5.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
5.12.2. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.3. South Africa
5.12.3.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.4. Saudi Arabia
5.12.4.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
5.12.5. UAE
5.12.5.1. Market estimates and forecast, by product, 2015 – 2026 (USD Million)
Chapter 6. Hemostasis and Tissue Sealing Agents Market – Competitive Analysis
6.1. Recent developments & impact analysis, by key market participants
6.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2018
6.4. Public Companies
6.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
6.4.2. Company Market Share/Ranking, by region
6.4.3. Competitive Dashboard Analysis
6.4.3.1. Market Differentiators
6.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
6.5. Private Companies
6.5.1. List of key emerging companies’ /technology disruptors/innovators
6.5.2. Funding Outlook (Optional)
6.5.3. Regional network map
6.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
6.6. Supplier Ranking
6.7. Key companies profiled
6.7.1. Johnson & Johnson
6.7.1.1. Company Overview
6.7.1.2. Financial Performance
6.7.1.3. Product Benchmarking
6.7.1.4. Strategic Initiatives
6.7.2. CryoLife Inc.
6.7.2.1. Company Overview
6.7.2.2. Financial Performance
6.7.2.3. Product Benchmarking
6.7.2.4. Strategic Initiatives
6.7.3. Advance Medical Solution (AMS) Group Plc.
6.7.3.1. Company Overview
6.7.3.2. Financial Performance
6.7.3.3. Product Benchmarking
6.7.3.4. Strategic Initiatives
6.7.4. Cohera Medical Inc.
6.7.4.1. Company Overview
6.7.4.2. Financial Performance
6.7.4.3. Product Benchmarking
6.7.4.4. Strategic Initiatives
6.7.5. Integra Life Sciences Corporation
6.7.5.1. Company Overview
6.7.5.2. Financial Performance
6.7.5.3. Product Benchmarking
6.7.5.4. Strategic Initiatives
6.7.6. Pfizer Inc.
6.7.6.1. Company Overview
6.7.6.2. Financial Performance
6.7.6.3. Product Benchmarking
6.7.6.4. Strategic Initiatives
6.7.7. C R Bard Inc.
6.7.7.1. Company Overview
6.7.7.2. Financial Performance
6.7.7.3. Product Benchmarking
6.7.7.4. Strategic Initiatives
6.7.8. Cohesion Technologies Inc.
6.7.8.1. Company Overview
6.7.8.2. Financial Performance
6.7.8.3. Product Benchmarking
6.7.8.4. Strategic Initiatives
6.7.9. HyperBranch Medical Technology.
6.7.9.1. Company Overview
6.7.9.2. Financial Performance
6.7.9.3. Product Benchmarking
6.7.9.4. Strategic Initiatives
6.7.10. Biomet Inc.
6.7.10.1. Company Overview
6.7.10.2. Financial Performance
6.7.10.3. Product Benchmarking
6.7.10.4. Strategic Initiatives
6.7.11. Covidien Plc.
6.7.11.1. Company Overview
6.7.11.2. Financial Performance
6.7.11.3. Product Benchmarking
6.7.11.4. Strategic Initiatives
6.7.12. B Braun Medical Inc.
6.7.12.1. Company Overview
6.7.12.2. Financial Performance
6.7.12.3. Product Benchmarking
6.7.12.4. Strategic Initiatives
6.7.13. Smith & Nephew.
6.7.13.1. Company Overview
6.7.13.2. Financial Performance
6.7.13.3. Product Benchmarking
6.7.13.4. Strategic Initiatives
Chapter 7. KOL Commentary
Chapter 8. Recommendation


【レポート販売概要】

■ タイトル:止血剤・組織密閉剤の世界市場:製品別(局所止血剤、接着剤・組織シーラント)、地域別、セグメント予測
■ 英文:Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Analysis Report By Product (Topical Hemostat, Adhesives & Tissue Sealant), By Region, And Segment Forecasts, 2019 - 2026
■ 発行日:2019年2月28日
■ 調査会社:Grand View Research
■ 商品コード:GVW903091
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。